| MTTI licenses Novel Targeting Agent from Medical College of Wisconsin | ||
| MTTI licenses robust NIR dye technology from Massachusetts General Hospital | 5/10/11 | read more |
| Jefferson Awarded Multi-Million Dollar NIH Grant | 10/12/10 | read more |
| Zn-DPA Cardiac Imaging Study Wins Competition | 9/22/10 | read more |
| University of Notre Dame and MTTI in Deal | 3/19/10 | read more |
| Molecular Targeting Technologies, Inc. Licenses Cell Targeting Technology from the University of Notre Dame | 3/1/10 | read more |
| LI-COR Sciences and MTTI Introduce CellVue® Dye Kits for Fluorescent Labeling of Cell Membranes | 3/2/09 | read more |
| MTTI has B-Bridge Inc. as a distributor for Japan. | 8/23/08 | read more |
| MTTI has engaged Dundee Cell Products as a distributor for Europe. | 8/22/08 | read more |
| MTTI will collaborate with Bexion to develop a novel nanovesicle for molecular imaging of tumors. | 4/22/08 | read more |
| MTTI and GENSEEN Partner to Develop Breast Cancer Gene Imaging Agent | 1/8/08 | read more |
| MTTI Licenses Novel Research Product Lines from PTIR | 8/8/07 | read more |
| Dr. Brian Gray Joins MTTI as Vice President of Research | 6/18/07 | read more |
| MTTI Receives Grant to Advance its Pivotal Phase II Clinical Trial in Acute Coronary Syndrome | 5/8/07 | read more |
| Dominance of the Rabies Virus G Protein Carrying a Non-Pathogenic Determinant over the G Protein Carrying a Pathogenic Determinant |
9/28/06 | read more |
| Identification of Pathogenicity Determinants of Rabies Virus (RV) and Assessment of the Role of the Rate of Virus Replication/Transcription in Pathogenesis |
9/27/06 | read more |
| MTTI Reports AMISCAN Phase II Clinical Results | 4/12/06 | read more |
| Tc-99m glucarate tumor image featured on the cover of Medical Physics Journal | 4/6/06 | read more |
| Chris Pak Speaks at the China TEDA Bioforum | 10/18/05 | read more |
| Evaluation of Prophylactic Efficacy of Human Anti-Rabies Monoclonal Antibodies in Mouse Model |
9/30/05 | read more |
| Characterization of Human Rabies Virus-Neutralizing Monoclonal Antibodies | 9/29/05 | read more |
| The Current Status of technetium-99m glucarate for Evaluation of Acute Coronary Syndromes |
9/28/05 | read more |
| Oral Vaccination of Skunks and Raccoons with Recombinant Rabies Virus Vaccines | 9/27/05 | read more |
| A Single Amino Acid exchange with the G Protein of a Non-Pathogenic RV | 3/28/05 | read more |
| Targeting of Human Lung-Cancer xenografts with Technetium-99m glucarate | 3/27/05 | read more |
| Scintigraphy of 99mTc-D-glucaric acid in Multiple Myeloma Patients | 3/25/05 | read more |
| Jefferson and MTTI Scientists Create New Vaccine for Wildlife Rabies | 12/9/04 | read more |
| BTSCAN May Improve Detection of Drug-Resistant Breast Cancer | 11/28/03 | read more |
| MTTI forms Partnership with North China Pharmaceutical Company | 9/18/03 | read more |
| DRAXIS Commences Phase II Clinical Study for AMISCAN | 2/13/01 | read more |